Patents by Inventor Stephane Billotte

Stephane Billotte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-heterocyclylpropanohydroxamic acids
    Patent number: 6897306
    Abstract: Compounds of formula (I): and their salts, solvates, prodrugs, etc., wherein the substituents have the values mentioned herein, are Procollagen C-Proteinase (PCP) inhibitors and have utility in conditions mediated by PCP.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: May 24, 2005
    Assignee: Pfizer Products, Inc.
    Inventors: Simon Bailey, Stephane Billotte, Paul Vincent Fish, Kim James, Nicholas Murray Thomson, Andrew Michael Derrick
  • 3-Heterocyclylpropanohydroxamic acids
    Publication number: 20030119807
    Abstract: Compound of formula (I): 1
    Type: Application
    Filed: July 16, 2002
    Publication date: June 26, 2003
    Inventors: Simon Bailey, Stephane Billotte, Paul Vincent Fish, Kim James, Nicholas Murray Thomson, Andrew Michael Derrick
  • Procollagen C-proteinase inhibitors
    Patent number: 6448278
    Abstract: Compounds of formula (I): and their salts, solvates, prodrugs, etc., wherein the substituents have the values mentioned herein, are Procollagen C-Proteinase (PCP) inhibitors and have utility in conditions mediated by PCP.
    Type: Grant
    Filed: December 13, 2000
    Date of Patent: September 10, 2002
    Assignee: Pfizer Inc.
    Inventors: Simon Bailey, Stephane Billotte, Andrew Michael Derrick, Paul Vincent Fish, Kim James, Nicholas Murray Thomson
  • Procollagen C-proteinase inhibitors
    Publication number: 20010021718
    Abstract: 1
    Type: Application
    Filed: December 13, 2000
    Publication date: September 13, 2001
    Inventors: Simon Bailey, Stephane Billotte, Andrew Michael Derrick, Paul Vincent Fish, Kim James, Nicholas Murray Thomson